Filed: 8/14/2026ACC: 0000935836-26-000415
📋 What this filing means
ECOR1 CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $2.06B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$2.06B
Total AUM (reported)
76.08M
Total Shares
Allocation by class
COM$1.78B86.5%
NAMEN AKT$75.77M3.7%
ORD SHS ADDED$63.87M3.1%
SPON ADR$49.98M2.4%
COM NEW$39.33M1.9%
SPONSORED ADS$23.10M1.1%
COMMON STOCK ADDED$10.39M0.5%
Portfolio Concentration
Top 3$1.29B62.6%
4–10$527.16M25.6%
11–25$225.20M10.9%
Rest$16.53M0.8%
Top 3 weight
62.6%
Top 10 weight
88.2%
Voting Authority Distribution
Total shares with voting rights: 76.08M
Sole
Full voting authority
76.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
ZYMEWORKS INC
SOLEShares22.97M
TypeSH
Market value$600.45M
29.19%
Sole
22.97M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares7.88M
TypeSH
Market value$531.91M
25.86%
Sole
7.88M
Shared
0.00
None
0.00
AKTIS ONCOLOGY INC
SOLEShares4.82M
TypeSH
Market value$155.49M
7.56%
Sole
4.82M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares2.06M
TypeSH
Market value$146.06M
7.10%
Sole
2.06M
Shared
0.00
None
0.00
ETON PHARMACEUTICALS INC
SOLEShares2.17M
TypeSH
Market value$78.62M
3.82%
Sole
2.17M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares1.39M
TypeSH
Market value$75.77M
3.68%
Sole
1.39M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$72.87M
3.54%
Sole
6.73M
Shared
0.00
None
0.00
FIRST TRACKS BIOTHERAPEUTICS
SOLEShares3.17M
TypeSH
Market value$63.87M
3.11%
Sole
3.17M
Shared
0.00
None
0.00
LAKEFRONT BIOTHERAPEUTICS NV
SOLEShares1.67M
TypeSH
Market value$49.98M
2.43%
Sole
1.67M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.27M
TypeSH
Market value$39.98M
1.94%
Sole
1.27M
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares735K
TypeSH
Market value$24.05M
1.17%
Sole
735K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares6.55M
TypeSH
Market value$23.97M
1.17%
Sole
6.55M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares800K
TypeSH
Market value$23.10M
1.12%
Sole
800K
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.82M
TypeSH
Market value$21.51M
1.05%
Sole
2.82M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares388.50K
TypeSH
Market value$21.45M
1.04%
Sole
388.50K
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares789.50K
TypeSH
Market value$20.04M
0.97%
Sole
789.50K
Shared
0.00
None
0.00
ATARA BIOTHERAPEUTICS INC
SOLEShares1.55M
TypeSH
Market value$17.82M
0.87%
Sole
1.55M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares697.95K
TypeSH
Market value$13.06M
0.63%
Sole
697.95K
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares1.67M
TypeSH
Market value$11.83M
0.58%
Sole
1.67M
Shared
0.00
None
0.00
ODYSSEY THERAPEUTICS INC
SOLEShares555.55K
TypeSH
Market value$10.39M
0.51%
Sole
555.55K
Shared
0.00
None
0.00
EIKON THERAPEUTICS INC
SOLEShares732.61K
TypeSH
Market value$9.56M
0.46%
Sole
732.61K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares235K
TypeSH
Market value$8.13M
0.40%
Sole
235K
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares1.18M
TypeSH
Market value$6.96M
0.34%
Sole
1.18M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares625K
TypeSH
Market value$6.78M
0.33%
Sole
625K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares270K
TypeSH
Market value$6.55M
0.32%
Sole
270K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZYMEWORKS INCSOLE | COM | 22.97M | SH | $600.45M 29.19% | 22.97M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 7.88M | SH | $531.91M 25.86% | 7.88M | 0.00 | 0.00 |
AKTIS ONCOLOGY INCSOLE | COM | 4.82M | SH | $155.49M 7.56% | 4.82M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 2.06M | SH | $146.06M 7.10% | 2.06M | 0.00 | 0.00 |
ETON PHARMACEUTICALS INCSOLE | COM | 2.17M | SH | $78.62M 3.82% | 2.17M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 1.39M | SH | $75.77M 3.68% | 1.39M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $72.87M 3.54% | 6.73M | 0.00 | 0.00 |
FIRST TRACKS BIOTHERAPEUTICSSOLE | ORD SHS ADDED | 3.17M | SH | $63.87M 3.11% | 3.17M | 0.00 | 0.00 |
LAKEFRONT BIOTHERAPEUTICS NVSOLE | SPON ADR | 1.67M | SH | $49.98M 2.43% | 1.67M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.27M | SH | $39.98M 1.94% | 1.27M | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 735K | SH | $24.05M 1.17% | 735K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 6.55M | SH | $23.97M 1.17% | 6.55M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 800K | SH | $23.10M 1.12% | 800K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 2.82M | SH | $21.51M 1.05% | 2.82M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 388.50K | SH | $21.45M 1.04% | 388.50K | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 789.50K | SH | $20.04M 0.97% | 789.50K | 0.00 | 0.00 |
ATARA BIOTHERAPEUTICS INCSOLE | COM NEW | 1.55M | SH | $17.82M 0.87% | 1.55M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 697.95K | SH | $13.06M 0.63% | 697.95K | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 1.67M | SH | $11.83M 0.58% | 1.67M | 0.00 | 0.00 |
ODYSSEY THERAPEUTICS INCSOLE | COMMON STOCK ADDED | 555.55K | SH | $10.39M 0.51% | 555.55K | 0.00 | 0.00 |
EIKON THERAPEUTICS INCSOLE | COM | 732.61K | SH | $9.56M 0.46% | 732.61K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 235K | SH | $8.13M 0.40% | 235K | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 1.18M | SH | $6.96M 0.34% | 1.18M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 625K | SH | $6.78M 0.33% | 625K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 270K | SH | $6.55M 0.32% | 270K | 0.00 | 0.00 |
Page 1 of 2